Anti-Desmin K5 antibody

Cat# NB-22-52778-250

Size : 250ul

Marca : Neo Biotech

Richiedere ulteriori informazioni

Contatta il distributore locale :


Telefono : +1 850 650 7790

  • Anti-Desmin K5 antibody

General Info

Host: Rabbit
Applications: IHC-F/IHC-P/WB
Reactivity: Human/Bovine/Caprine/Chicken/Hamster/Mouse/Rat/Zebrafish
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Desmin K5 is suitable for use in Immunohistochemistry and Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Formulation: PBS with 0.09% sodium azide
Purification: Affinity purified
Dilution Range: IHC-F 1:25-1:100
IHC-P 1:25-1:100
WB 1:100-1:500
Storage Instruction: Store at 2-8°C upon receipt.

Information

Immunogen: anti Chicken gizzard muscle desmin

Description

Background Desmin is a 53 kDa intermediate filament protein and exhibits a high degree of tissue specificity, its expression being predominantly confined to all types of muscle cells (cardiac, skeletal and smooth muscle). Regulation of desmin expression is stage and tissue-specific, since it is induced during terminal development and muscle cell differentiation. In skeletal en cardiac muscle cells desmin is localized in the Z-disk region and at the intercalated disk. The expression pattern of desmin in smooth muscle is much more heterogenous. Coexpression of desmin and vimentin has been observed in tumors derived from muscle tissue, i.e. rhabdomyosarcomas and leiomyosarcomas. Furthermore, during myocard dysfunction dramatic changes in the distribution of desmin have been observed. RCK106 reacts exclusively with Cytokeratin 18 in glandular epithelial cells of the digestive, respiRatory, and urogenital tracts, endocrine and exocrine cells and mesothelial cells, as well as adenocarcinomas originating from them.

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance